Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants

Journal of Perinatology

Volumn 35, Issue 5, 2015, Pages 357-361

  Christensen, R D ^a,b   Agarwal, A M ^b,c   Nussenzveig, R H ^b   Heikal, N ^b,c   Liew, M A ^b   Yaish, H M ^b  

^a Intermountain Healthcare ^*  (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; EOSIN 5 MALEIMIDE; UNCLASSIFIED DRUG; EOSIN; EOSIN MALEIMIDE;

ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ELLIPTOCYTOSIS; ERYTHROCYTE TRANSFUSION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GESTATIONAL AGE; HEREDITARY SPHEROCYTOSIS; HETEROZYGOSITY; HUMAN; INFANT; MALE; MUTATION; NEWBORN; NEXT GENERATION SEQUENCING; RETICULOCYTOSIS; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; ERYTHROCYTE DISORDER; GENETICS; HIGH THROUGHPUT SEQUENCING; NEWBORN SCREENING; SPHEROCYTOSIS, HEREDITARY;

CASE-CONTROL STUDIES; EOSINE YELLOWISH-(YS); FLOW CYTOMETRY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; SPHEROCYTES; SPHEROCYTOSIS, HEREDITARY;

EID: 84929129566     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2014.202     Document Type: Article

References (33)

1. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA kernicterus registry (1992-2004). J Perinatol 2009; 29(Suppl 1): S25-S45
2. Christensen RD, Yaish HM, Nussenzveig RH, Reading NS, Agarwal AM, Eggert LD., et al. Acute kernicterus in a neonate with O/B blood group incompatibility and a mutation in SLC4A1. Pediatrics 2013; 132(2): e531-e534
3. Gallagher PG. Abnormalities of the erythrocyte membrane. Pediatr Clin North Am 2013; 60(6): 1349-1362
4. Christensen RD, Henry E. Hereditary spherocytosis in neonates with hyperbilirubinemia. Pediatrics 2010; 125(1): 120-125
5. Sheffield MJ, Christensen RD. Evaluating neonatal hyperbilirubinemia in late preterm Hispanic twins led to the diagnosis of hereditary spherocytosis in them, and in their sibling and in their mother. J Perinatol 2011; 31(9): 625-627
6. Christensen RD, Yaish HM, Lemons RS. Neonatal hemolytic jaundice: Morphologic features of erythrocytes that will help you diagnose the underlying condition. Neonatology 2014; 105(4): 243-249
7. Bianchi P, Fermo E, Vercellati C, Marcello AP, Porretti L, Cortelezzi A., et al. Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics. Haematologica 2012; 97(4): 516-523
8. Kedar PS, Colah RB, Kulkarni S, Ghosh K, Mohanty D. Experience with eosin-5'- maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders. Clin Lab Haematol 2003; 25(6): 373-376
9. King MJ, Smythe JS, Mushens R. Eosin-5-maleimide binding to band 3 and Rhrelated proteins forms the basis of a screening test for hereditary spherocytosis. Br J Haematol 2004; 124: 106-113
10. King MJ, Telfer P, MacKinnon H, Langabeer L, McMahon C, Darbyshire P., et al. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. Cytometry B Clin Cytom 2008; 74(4): 244-250
11. Kar R, Mishra P, Pati HP. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis. Int J Lab Hematol 2010; 32(1 Pt 2): 8-16
12. Kar R, Rao S, Srinivas UM, Mishra P, Pati HP. Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India. Hematology 2009; 14(3): 164-167
13. Tachavanich K, Tanphaichitr VS, Utto W, Viprakasit V. Rapid flow cytometric test using eosin-5-maleimide for diagnosis of red blood cell membrane disorders. Southeast Asian J Trop Med Public Health 2009; 40(3): 570-575
14. King MJ, Jepson MA, Guest A, Mushens R. Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins. Int J Lab Hematol 2011; 33(2): 205-211
15. D'Alcamo E, Agrigento V, Sclafani S, Vitrano A, Cuccia L, Maggio A., et al. Reliability of EMA binding test in the diagnosis of hereditary spherocytosis in Italian patients. Acta Haematol 2011; 125(3): 136-140
16. Ciepiela O, Kotula I, Górska E, Stelmaszczyk-Emmel A, Popko K, Szmydki-Baran A., et al. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis. Clin Chem Lab Med 2013; 51(4): 817-823
17. Golafshan HA, Ranjbaran R, Kalantari T, Moezzi L, Karimi M, Behzad-Behbahani A., et al. Evaluation of red cell membrane cytoskeletal disorders using a flow cytometric method in South Iran. Turk J Haematol 2014; 31(1): 25-31
18. Watanabe T, Ono H, Tajima I, Ishigaki H, Hakamata A, Shirai M., et al. Hereditary spherocytosis diagnosed with the eosin-5'-maleimide binding test. Pediatr Int 2014; 56(3): 427-429
19. Christensen RD, Nussenzveig RH, Yaish HM, Henry E, Eggert LD, Agarwal AM. Causes of hemolysis in neonates with extreme hyperbilirubinemia. J Perinatol 2014; 34(8): 616-619
20. Henry E, Christensen RD, Sheffield MJ, Eggert LD, Carroll PD, Minton SD., et al. Why do four NICUs using identical RBC transfusion guidelines have different gestational age-adjusted RBC transfusion rates?. J Perinatol (epub ahead of print 25 September 2014
21. Delhommeau F, Cynober T, Schischmanoff PO, Rohrlich P, Delaunay J, Mohandas N., et al. Natural history of hereditary spherocytosis during the first year of life. Blood 2000; 95: 393-397
22. Gallagher PG. Disorders of red cell volume regulation. Curr Opin Hematol 2013; 20 (3): 201-207
23. Bogardus HH, Maksimova YD, Forget BG, Gallagher PG. A de novo band 3 mutation in hereditary spherocytosis. Pediatr Blood Cancer 2012; 58(6): 1004
24. Sangerman J, Maksimova Y, Edelman EJ, Morrow JS, Forget BG, Gallagher PG. Ankyrin-linked hereditary spherocytosis in an African-American kindred. Am J Hematol 2008; 83(10): 789-794
25. Gallagher PG. Hematologically important mutations: ankyrin variants in hereditary spherocytosis. Blood Cells Mol Dis 2005; 35(3): 345-347
26. Gundel F, Eber S, Heep A. A new ankyrin mutation (ANK1 EXON E9X) causing severe hereditary spherocytosis in the neonatal period. Ann Hematol 2011; 90(2): 231-232
27. Berardi A, Lugli L, Ferrari F, Gargano G, D'Apolito M, Marrone A., et al. Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism. Biol Neonate 2006; 90(4): 243-246
28. Saada V, Cynober T, Brossard Y, Schischmanoff PO, Sender A, Cohen H., et al. Incidence of hereditary spherocytosis in a population of jaundiced neonates. Pediatr Hematol Oncol 2006; 23(5): 387-397
29. Crisp RL, Solari L, Vota D, Garcia E, Miguez G, Chamorro ME., et al. A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5'-maleimide flow cytometry, osmotic fragility tests, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina. Ann Hematol 2011; 90(6): 625-634
30. Girodon F, Garcon L, Bergoin E, Larger M, Delaunay J, Feneant-Thibault M., et al. Usefulness of the eosin-5'maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis. Br J Haematol 2008; 140(4): 468-470
31. Yaish HM, Christensen RD, Henry E, Baer VL, Bennett S. A simple method of screening newborn infants for hereditary spherocytosis. J Applied Hematol 2013; 4: 27-32
32. Yaish HM, Christensen RD, Agarwal A. A neonate with Coombs-negative hemolytic jaundice with spherocytes but normal erythrocyte indices: a rare case of autosomal-recessive hereditary spherocytosis due to alpha-spectrin deficiency. J Perinatol 2013; 33(5): 404-406
33. Nussenzveig RH, Christensen RD, Prchal JT, Yaish HM, Agrawal AM. Novel alpha spectrin mutation in trans with alpha spectrinLEPRA resulting in severe, nondominant, hereditary spherocytosis. Neonatology 2014; 105(4): 355-357